Search

Displaying results 8821 - 8830 of 10000 in total
  1. Drug

    Gedivumab

    go.drugbank.com/drugs/DB15277
    Investigational

    Gedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).

  2. Drug

    Exicorilant

    go.drugbank.com/drugs/DB16162
    Investigational

    Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).

  3. Drug

    N-sulfoglucosamine sulfohydrolase recombinant

    go.drugbank.com/drugs/DB12722
    Investigational

    N-sulfoglucosamine sulfohydrolase recombinant is under investigation for the treatment of Mucopolysaccharidosis III and Sanfilippo Syndrome Type A (MPS IIIA).

  4. Drug

    Ruxotemitide

    go.drugbank.com/drugs/DB12748
    Investigational

    LTX-315 has been used in trials studying the treatment of Cancer, Lymphoma, Melanoma, Carcinoma, and Breast Cancer, among others.

  5. Drug

    Condoliase

    go.drugbank.com/drugs/DB12793
    Investigational

    Condoliase has been used in trials studying the treatment of Lumbar Disc Disease, Lumbar Vertebra Hernia, and Intervertebral Disc Disease.

  6. Drug

    Ozanezumab

    go.drugbank.com/drugs/DB12891
    Investigational

    Ozanezumab has been used in trials studying the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.

  7. Drug

    Lomibuvir

    go.drugbank.com/drugs/DB11954
    Investigational

    Lomibuvir has been used in trials studying the treatment of Chronic Hepatitis C Virus and Chronic Hepatitis C Virus Infection.

  8. Drug

    Dinaciclib

    go.drugbank.com/drugs/DB12021
    Investigational

    Dinaciclib has been used in trials studying the treatment of rrMM, rrCLL, rrDLBCL, Solid Tumors, and Solid Neoplasm, among others.

  9. Drug

    Ganetespib

    go.drugbank.com/drugs/DB12047
    Investigational

    Ganetespib is under investigation for the treatment of BREAST CANCER, Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome.

  10. Drug

    UK-396,082

    go.drugbank.com/drugs/DB12099
    Investigational

    UK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.